Application Note: WB: 1:500-1:2000. ICC/IF: 1:100-1:500. IHC-P: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 251
Form: Liquid
Buffer (with preservative): PBS, 150mM NaCl, 50% Glycerol, 0.02% sodium azide.
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration.)
Background: A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008]
Uniprot ID: Q6UVK1
Antigen Species: Human
Immunogen: A synthesized peptide derived from human CSPG4(Accession Q6UVK1), corresponding to amino acid residues A1854-R1874.
Purification: Purified by antigen-affinity chromatography
Conjugation: Unconjugated
Full Name: chondroitin sulfate proteoglycan 4
English
Deutsch
